|
|
|
07.07.26 - 10:15
|
Bayer, BASF, Novo Nordisk? Das ist unser Geheimtipp! (Sharedeals)
|
|
|
Während die internationalen Aktienmärkte weiter auf Konjunkturdaten, Zinsperspektiven und Unternehmensnachrichten reagieren, rücken auch einige europäische Schwergewichte verstärkt in den Fokus der Anleger. Bayer, BASF und Novo Nordisk sorgen derzeit mit unterschiedlichen Entwicklungen für Gesprächsstoff – von juristischen Fortschritten über Konjunkturhoffnungen bis hin zu charttechnischen Signalen. Bayer: Die Bayer-Aktie konnte zuletzt deutlich zulegen. Auslöser waren unter […]
The post Bayer, BASF, Novo Nordisk? Das ist unser Geheimtipp! first appeared on sharedeals.de....
|
|
|
|
|
|
|
01.07.26 - 16:30
|
Airbus-Aktie: BofA sieht Potenzial – jetzt noch einsteigen? (Sharedeals)
|
|
|
Die Bank of America hat zum Start des dritten Quartals ihre Favoritenliste für europäische Aktien aktualisiert. Analyst Eric Lopez nennt Airbus, Atlas Copco, Compass Group, Ferguson, Kingspan Group, Orsted und Relx als klare Kaufkandidaten. Auf der anderen Seite stehen BASF, Lanxess und Legrand, die Lopez als "Underperformer" einstuft. Airbus mit großen Erwartungen am 21. Juli […]
The post Airbus-Aktie: BofA sieht Potenzial – jetzt noch einsteigen? first appeared on sharedeals.de....
|
|
|
|
|
23.06.26 - 07:30
|
Novonesis on Business Strategy (Bloomberg)
|
|
|
Ester Baiget, CEO of Danish biosolutions company Novonesis, discusses the firm's China business and growth strategy. She speaks with Minmin Low from the sidelines of the World Economic Forum's Annual Meeting of the New Champions in Dalian. (Source: Bloomberg)...
|
|
|
23.06.26 - 06:12
|
Ester Baiget never planned to be CEO. Then a future bioscience giant came calling (CNBC)
|
|
|
Novonesis CEO Ester Baiget reflects on the decision to leave Dow after 25 years to lead Novozymes, and why impact, not ambition, drove the move. She discusses the family values that shaped her, redefining the company as a biosolutions leader, the Chr. Hansen merger and why leadership requires courage, respect and long-term purpose....
|
|
|
|
|
|
|
|
|
|
|
06.05.26 - 14:48
|
Trading by management and close relations of management (GlobeNewswire EN)
|
|
|
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the “Market Abuse Regulation”) and commission delegated regulation (EU) 1052/2016 of 8 March 2016, Novonesis reports the following transactions under ISIN DK0060336014, Novonesis (Novozymes) B shares under the symbol NSIS B....
|
|
|
|
|
05.05.26 - 14:42
|
′Irrationally High′ Risk of Iran War Restarting: Bloomberg Opinion′s Champion | The Pulse 5/5 (Bloomberg)
|
|
|
"The Pulse With Francine Lacqua" is all about conversations with high profile guests in the beating heart of global business, economics, finance and politics. Based in London, we go wherever the story is, bringing you exclusive interviews and market-moving scoops.
Today's guests:
Vivek Paul, BlackRock Investment Institute, Portfolio Research Global Head; Yu Jie, Chatham House, Asia-Pacific Programme Senior Research Fellow; Ester Baiget, Novonesis, President & CEO; Massimo Battaini, Prysmian, CEO. (Source: Bloomberg)...
|
|
|
|
|
|
|
|
|
|
|
|
|
11.04.26 - 01:18
|
Mistry pitches for Tata holdco to go public (Times of India)
|
|
|
Shapoor Mistry, representing the largest minority shareholder, advocates for Tata Sons' public listing, calling it essential for stakeholder value and trust income. This follows similar calls from Tata Trusts vice chairmen, amid RBI's proposed NBFC norms. Mistry believes a listing will enhance governance and transparency, potentially easing SP Group's debt pressures....
|
|